Close Menu

NEW YORK – Belgian molecular diagnostics firm Biocartis said on Tuesday it has signed a license, development, and commercialization agreement with startup GeneproDx to develop GeneproDx's ThyroidPrint on Biocartis' Idylla platform, as well as a separate agreement with Endpoint Health to develop and commercialize a novel companion diagnostic (CDx) test on the Idylla instrument.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.